When purchasing a minority interest in a multispecialty facility, 50 percent of companies see prevailing valuation multiples of 4 times to 4.9 times EBITDA, according to HealthCare Appraisers' 2018 ASC Valuation Survey.
Data was collected from 15 respondents representing 700-plus U.S. surgery centers.
Here are 16 statistics on the valuation multiples most typically observed for various interests in predominantly in-network centers:
Minority interest, single-specialty
1. 2 to 2.9 times: 8 percent
2. 3 to 3.4 times: 23 percent
3. 3.5 to 3.9 times: 15 percent
4. 4 to 4.9 times: 38 percent
5. 5 to 5.9 times: 15 percent
Controlling interest, single-specialty
6. 5 to 5.9 times: 23 percent
7. 6 to 6.9 times: 38 percent
8. 7 to 7.9 times: 38 percent
Minority interest, multispecialty
9. 3 to 3.4 times: 14 percent
10. 3.5 to 3.9 times: 21 percent
11. 4 to 4.9 times: 50 percent
12. 5 to 5.9 times: 7 percent
13. 6 to 6.9 times: 7 percent
Controlling interest multispecialty
14. 6 to 6.9 times: 29 percent
15. 7 to 7.9 times: 64 percent
16. 8+: 7 percent